Research Interests
Noninvasive Neuromodulation for Addiction and Psychiatric Disorders
My primary research focuses on the development and evaluation of noninvasive brain stimulation approaches—particularly repetitive transcranial magnetic stimulation (rTMS)—for the treatment of tobacco use disorder, substance use disorders, and treatment-resistant psychiatric conditions. A major emphasis is on high-risk populations, including veterans with posttraumatic stress disorder (PTSD). Current projects include multimodal interventions that combine neuroimaging-guided rTMS with behavioral therapy and pharmacotherapy to improve cessation outcomes and durability of response.
Precision Targeting and Neuroimaging-Guided InterventionsI investigate the use of structural and functional MRI, functional connectivity mapping, and computational head modeling to optimize individualized TMS targeting and dosing. This work aims to improve mechanistic understanding, enhance clinical efficacy, and advance personalized neuromodulation protocols.
Artificial Intelligence and Evidence Synthesis in NeuromodulationThrough interdisciplinary collaborations and the Bass Connections program, I lead efforts to integrate artificial intelligence and machine learning into evidence synthesis and research infrastructure. This includes development of WikiStim.org, an AI-enhanced repository of neuromodulation studies designed to support systematic reviews, meta-analyses, and data-driven clinical decision-making.
Clinical Trials and Translational ImplementationMy research includes the design and conduct of randomized clinical trials evaluating neuromodulation-based treatments. I am particularly interested in issues of feasibility, scalability, and real-world implementation within academic and Veterans Health Administration settings, with the goal of accelerating translation from research to clinical practice.
Neuroethics and Responsible InnovationI examine the ethical, equity, and policy implications of emerging neuromodulation technologies, including access, consent, data governance, and clinical deployment. This work informs responsible innovation and supports the development of ethically grounded clinical frameworks.
Key Areas of Focus- Transcranial magnetic stimulation (TMS)
- Tobacco and substance use disorders
- Neuroimaging-guided intervention
- Artificial intelligence in clinical research
- Precision psychiatry
- Neuroethics and health policy
- Veteran mental health
Fellowships, Gifts, and Supported Research
External Relationships
- Synaptiq Neurotech, Inc.
- Synaptiq Psychiatry, PLLC
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.